Molecular malignancy in melanocytic lesions

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9758829
APP PUB NO 20150176072A1
SERIAL NO

14405739

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are methods for determining whether a melanocyte-containing sample (such as a nevus or other pigmented lesion) is benign or a primary melanoma. These methods can include detecting (at the molecular level, e.g., mRNA, miRNA, or protein) the expression of at least two disclosed genes in a biological sample obtained from a subject. Also provided are arrays and kits that can be used with the methods.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HTG MOLECULAR DIAGNOSTICS INC3430 E GLOBAL LOOP TUCSON AS 85706

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hoon, Dave S B Los Angeles, US 25 374
Kerns, B J Madison, US 1 1
Lu, Zhenquiang Tucson, US 2 75
Maddula, Krishna Tucson, US 3 75
Roberts, Christopher Tucson, US 26 246
Seligmann, Bruce E Tucson, US 4 21
Vasicek, Tom Minneapolis, US 2 111
Wang, Hui San Bruno, US 1115 8921

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 12, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 12, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00